AEGiS-UNAIDS: Statement on HIV prevalence estimates in India

Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

Statement on HIV prevalence estimates in India

UNAIDS Press Statement - June 8, 2007

Geneva, 8 June 2007 û As part of its continuous efforts to know its epidemic better, the National AIDS Control Organization (NACO) leads an annual process, together with national and international expert groups, including UNAIDS and WHO to estimate the number of adults living with HIV in India (HIV prevalence). From 4-6 June, 2007, NACO convened a meeting of the Core Technical Working Group on Estimates and Projections, which provides guidance on the methods and assumptions used to develop national HIV prevalence estimates. This year the estimates would provide a more accurate picture of the epidemic because of availability of more information based on population based surveys and improved data from high risk groups. The Working Group is still in the process of analyzing the data to develop an updated estimate of national HIV prevalence and these figures will be available by the first week of July.

Some trends can already be identified from the analysis of existing sentinel data. Although prevalence in antenatal clinics has shown a decline in some southern states, high levels of infection among the groups at higher risk, such as Men who have Sex with Men (MSM), and Injecting Drug Users (IDU) are of concern. Similarly, while data does suggest that the HIV prevalence levels are declining among sex workers in areas where targeted interventions have been implemented, particularly in the southern states, yet overall prevalence levels among this group continue to be high necessitating focused prevention interventions. Experience shows that where these groups are themselves engaged in prevention efforts they become strong leaders in prevention. Finally, the 2007 sentinel data clearly validates the prevention strategy being implemented by NACO.

Contact details

Manisha Mishra | UNAIDS India | + 91 98 10 88 2273 | mishram@unaids.org

070608
UN070607

Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .